PPA-containing medicines ban having little impact to six Korea drug makers in Korea Stock Exchange

Overall, the share prices of six pharmaceutical firms producing phenylpropanolamine (PPA) based cold remedies showed little sign of plunge between July 30 to August 5, despite the recent jitters over PPA drugs ban.

Though a correction is expected, this in itself will not likely become a barrier to the upward mood that so far has prevailed in the domestic pharmaceutical market. Detail...